Exchange: NYSEMkt·Updated 11:48 AM EDT
MYO logo

MYOMyomo Inc

$1.20
$0.02
(1.70%)
Today
EarningsAug 10
Mkt Cap$45.59M
Vol179,143.00
News
all
press releases
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock
Myomo (MYO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks
News Placeholder
More News
News Placeholder
Here Is Why Bargain Hunters Would Love Fast-paced Mover Myomo (MYO)
Myomo (MYO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks
News Placeholder
Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +21.74% and +8.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +5.88% and +11.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Cresco Labs Inc. (CRLBF) Reports Q4 Loss, Beats Revenue Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +14.16% and +0.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of +18.18% and +8.74%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +10.31% and +6.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Why Medical Device Maker Myomo’s Stock Crashed 42% In After-Hours Trading
The wearable medical robotics maker slashed its 2025 revenue forecast and posted a wider-than-expected quarterly loss due to weaker lead quality, slower conversions, and rising costs.
Stocktwits
News Placeholder
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
Myomo (MYO) delivered earnings and revenue surprises of 0.00% and +6.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
Capricor (CAPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
<
1
2
...
>

Advertisement|Remove ads.